Convex CRO and Phase I Clinical Research Center Partners with Stanidobrovolets to Power Volunteer аnd Patient Recruitment for Clinical Research in Bulgaria

Convex CRO and Phase I Unit, a leading clinical research organization based in Sofia, Bulgaria, proudly announces a strategic partnership with Stanidobrovolets – the country’s premier platform for volunteer and patient recruitment in clinical trials.

This collaboration brings together Convex’s robust clinical infrastructure and operational excellence with the extensive volunteer and patient network of Stanidobrovolets. The goal: to enhance recruitment capacity for both healthy volunteers and specific patient populations across a broad range of clinical studies.

“Combining our Phase I capabilities and outpatient research center with the recruitment power of Stanidobrovolets allows us to deliver faster, higher-quality enrollment – something every sponsor values,” said Dimitar Mirchev, Managing Director at Convex.

About Stanidobrovolets

Stanidobrovolets is Bulgaria’s leading platform for clinical trial volunteer engagement. With a growing community of healthy individuals and patients willing to participate in research, the platform has helped accelerate recruitment timelines and increase patient retention for numerous clinical trials in Bulgaria.

Through digital outreach, educational materials, and personalized communication, Stanidobrovolets ensures that participants are well-informed, motivated, and committed to the research process. The platform has become a trusted ally for CROs and pharmaceutical sponsors seeking reliable recruitment solutions.

What This Means for Clinical Trials in Bulgaria

This partnership enables streamlined, ethical, and high-quality recruitment for even the most challenging study populations. Whether it’s healthy volunteer trials in Phase I or targeted variety of study population Convex and Stanidobrovolets offer a complete solution – from recruitment to results.

Looking Ahead

Several joint projects are already in development. With a strong pipeline of Phase I and III studies scheduled for the second half of 2025. This collaboration reaffirms Bulgaria’s role as a growing hub for clinical research and underlines Convex’s commitment to innovation, speed, and patient-centered excellence.

For inquiries or collaboration opportunities, please contact:
info@convex.bg or office@stanidoborovolets.com